SEC Filing Summary for Adicet Bio, Inc.

On June 19, 2026, Schor Chen, President & CEO of Adicet Bio, Inc. (ACET), acquired 55,000 stock options with a right to buy common stock. The options have an exercise price of $8.10 and are subject to a vesting schedule of 1/48th of the shares monthly over 48 months, with partial acceleration tied to performance milestones, provided the reporting person maintains a service relationship with the Issuer. The options were granted with a transaction price of $0.0 per share and expire on June 18, 2036. Following this transaction, Mr. Chen directly owns 55,000 shares underlying these options.